Combination of Low-Dose Gemcitabine and PD-1 Inhibitors for Treatment in Patients With Advanced Malignancies

PURPOSE: This study determined the efficacy of low-dose gemcitabine combined with programmed death-1 (PD-1) inhibitors for treating multiple malignancies, providing a cost-effective and safe treatment option. STUDY DESIGN: This study included 61 patients with advanced solid tumors treated with low-d...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Hao, Peng, Ling, Zhang, Bicheng, Till, Brian G., Yang, Yonghao, Zhang, Xiaojie, Zhao, Lingdi, Fu, Xiaomin, Li, Tiepeng, Han, Lu, Qin, Peng, Chen, Lin, Yan, Xiang, Liu, Yang, Wang, Wenkang, Ye, Zhenlong, Li, Hongle, Gao, Quanli, Wang, Zibing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328170/
https://www.ncbi.nlm.nih.gov/pubmed/35911715
http://dx.doi.org/10.3389/fimmu.2022.882172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328170/
https://www.ncbi.nlm.nih.gov/pubmed/35911715
http://dx.doi.org/10.3389/fimmu.2022.882172

Ejemplares similares